Table 1: Baseline characteristics of included patients.

Author (year)Average AgeAverage MR GradeMale Sex %Previous Afib %NYHA III-IV (%)Average LVEF %
Overall (Treatment/Control)Overall (Treatment/Control)Overall (Treatment/Control)Overall (Treatment/Control)Overall (Treatment/Control)

Velazquez, 201573.7 (73.7)3-4+57.1 (59.8/54.4)33 (33/33)33.21 (34/32)
Asgar, 201671.8 (75/68)3-4+75.37 (74/77)39 (35/43)74.5 (73/76)36 (37/35)
Armeni, 201671 (71/71)73.39 (73/74)49.48 (53/40.7)87.87 (88.5/86.4)36.11 (36.8/34.5)
Giannini, 201675.5 (75/76)3-4+66.5 (70/63)61.55 (64.9/58.2)79 (78.2/79.8)41.75 (41.5/42)
Geis, 201762.01 (68.2/54.3)41.57 (74.4/0.65)58.82 (61.6/52.8)54.65 (54.4/55.2)
Obadia, 201870.35 (70.1/70.6)3-4+74.65 (78.9/70.4)51.29 (55.6/43)56.8 (86.3/61.9)36.07 (37.22/33.85)
Kortlandt, 201874.02 (73.96/74.15)3-4+54.93 (56.5/51.9)46.3 (65.0/23)25.45 (25/26)
Stone, 201872.26 (71.7/72.8)3-4+64.01 (66.6/61.5)55.22 (57.3/53.2)60.86 (57/64.6)31.3 (31.3/31/3)

MR: mitral regurgitation; Afib: atrial fibrillation; NYHA: New York Heart Association; LVEF: left ventricular ejection fraction.